Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly

Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly

FromThe Hematologist


Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly

FromThe Hematologist

ratings:
Length:
19 minutes
Released:
Jan 10, 2023
Format:
Podcast episode

Description

In this installment, Contributing Editor Dr. Lori Muffly has a conversation with Dr. Partow Kebriaei. They discuss the Blood article covered by Dr. Muffly in her most recent Diffusion article titled, “Should Minimal Residual Disease Guide the Way? The Evolving Role of Allogeneic Hematopoietic Cell Transplantation for Adults With Ph+ Acute Lymphoblastic Leukemia in First Complete Remission.” In the article, Dr. Muffly explored the study by Drs. Ghobadi, Kebriaei, and colleagues, which examined the impact of allogeneic hematopoietic cell transplantation in adults with Ph+ acute lymphoblastic leukemia achieving deep molecular remission.You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.6.202267/486876/Should-Minimal-Residual-Disease-Guide-the-Way-The.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/ 
Released:
Jan 10, 2023
Format:
Podcast episode

Titles in the series (100)

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.